Advanced Medical Solutions Group plc (AIM:AMS)
London · Delayed Price · Currency is GBP · Price in GBX 215.00
-2.00 (-0.92%)
Oct 31, 2025, 4:44 PM GMT+1
AIM:AMS Revenue
Advanced Medical Solutions Group had revenue of 110.77M GBP in the half year ending June 30, 2025, with 75.58% growth. This brings the company's revenue in the last twelve months to 220.30M, up 68.03% year-over-year. In the year 2024, Advanced Medical Solutions Group had annual revenue of 177.52M with 40.66% growth.
Revenue (ttm)
220.30M
Revenue Growth
+68.03%
P/S Ratio
2.10
Revenue / Employee
146.87K
Employees
1,600
Market Cap
463.50M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 177.52M | 51.31M | 40.66% |
| Dec 31, 2023 | 126.21M | 1.88M | 1.51% |
| Dec 31, 2022 | 124.33M | 15.73M | 14.48% |
| Dec 31, 2021 | 108.60M | 21.81M | 25.12% |
| Dec 31, 2020 | 86.80M | -15.57M | -15.21% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |